Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ILLUCCIX safely and effectively. See full prescribing information for ILLUCCIX. ILLUCCIX® (kit for the preparation of gallium Ga 68 gozetotide injection), for intravenous use Initial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
ILLUCCIX, after radiolabeling with Ga 68, is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: With suspected metastasis who are candidates for initial definitive therapy. With suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. For selection of patients with metastatic prostate cancer, for whom lutetium Lu 177 vipivotide tetraxetan PSMA-directed therapy is indicated.
- generic_name
- kit for the preparation of gallium ga 68 gozetotide injection
- brand_name
- PSMA-11, Sodium Acetate anhydrous
- product_names
- Kit for the preparation of gallium Ga 68 gozetotide injection, PSMA-11, Sodium Acetate anhydrous
- ndc
- 74725-101, 74725-100, 74725-100-25, 74725-100-64, 74725-101-25, 74725-102, 74725-102-25, 74725-103, 74725-103-64
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en